Glaukos Corporation
Overview
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on developing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery (MIGS) and offers a range of innovative products, including the iStent platform and the iDose TR implant.
Therapeutic areas
FDA compliance signals
1 FDA enforcement record linked to this company.
- 4832025-04-22
Investigations of discrepancies, failures
Is this Glaukos Corporation? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.